Modified short-course radiotherapy

RADIATION2 trials

Sponsors

Sir Run Run Shaw Hospital, Fujian Cancer Hospital

Conditions

Locally Advanced Rectal CancerLow Rectal Cancer

Phase 2

Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer

RecruitingNCT05972655

Sir Run Run Shaw HospitalLow Rectal Cancer

Start: 2023-08-02End: 2026-05-01Target: 32Updated: 2025-01-09

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

Not yet recruitingNCT07469306

Fujian Cancer HospitalLocally Advanced Rectal Cancer

Start: 2026-08-10End: 2027-09-01Target: 130Updated: 2026-03-13

Related Papers

Node-sparing modified short-course Radiotherapy Combined with CAPOX and Tislelizumab for locally Advanced MSS of Middle and low rectal Cancer (mRCAT): an open-label, single-arm, prospective, multicentre clinical trial.

2024-10-091 citations

Node-sparing modified short-course radiotherapy combined with CAPOX and tislelizumab for locally advanced MSS of middle and low rectal cancer (mRCAT): An open-label, single-arm, prospective, multicentre clinical trial.

Journal of Clinical Oncology2024-01-20